Clinical Trial Update: Safety Evaluation of Use Sodic Enoxaparin [Phase 3]

View source ↗

Summary

A Phase 3 safety evaluation of sodium enoxaparin in patients with kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Sodium Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Azidus Brasil | Conditions: Kidney Disease | Phase 3 | Status: COMPLETED